I urge you to cosponsor H.R. 2565 and to urge all House leaders to bring the FDA Modernization Act 2.0 (S.5002) to the House floor as soon as possible. The Senate unanimously passed S. 5002, and the bill can go to President Biden if the House gets a chance to vote on it.
The FDA Modernization Act is a transformative bill that would eliminate an 84-year-old requirement for animal testing for new drugs and vaccines. It would enable the transition to non-animal test methods to test the safety and efficacy of new drugs such as advanced cell-based assays, organ chips, sophisticated computer modeling, and other human biology-based test methods.
The importance of this historic bill cannot be overstated and is echoed in the excitement from the biotech industry and health care advocates.
Biotech company, CN BIO, called the FDA Modernization Act, “a giant step towards a world without animal testing”.
Dr. Isaac Bentwich, CEO of Quris, a drug development company which integrates organ chip technology with artificial intelligence, has said, “Removing the reliance on antiquated and inaccurate animal testing models in drug development is not only a win for animals, it is a win for entire industry and will ensure improved drug safety, better patient outcomes and more efficient drug innovation … Spurred by new regulations like the FDA Modernization Act, drug developers will likely race to embrace breakthrough innovations.”
An editorial published in the Wall Street Journal on October 5 wrote, referring to the FDA Modernization Act, “If the law changes, pharmaceutical companies could rely on more-accurate tests before beginning human trials, allowing safer and more effective drugs to advance toward commercialization.”
The FDA Modernization Act is a groundbreaking bill that can enhance the delivery of safer drugs while reducing animals. I urge you to co-sponsor the bill and support bringing it to the House floor for a vote.